Dr Reddy’s Laboratories said on Monday that a proposed deal to acquire the drug prescription portfolio of JB Chemicals & Pharmaceuticals in Russia and other CIS countries has been mutually called off in the overall business interest of both parties.
The Anji Reddy-led Dr Reddy’s did not elaborate on the reasons for terminating the proposed acquisition,in its statement to the National Stock Exchange (NSE).
You have exhausted your monthly limit of free stories.
Read more stories for free with an Express account.
